
Aurora Cannabis ACB
€ 3.16
5.32%
Geschäftsbericht 2025
hinzugefügt 21.02.2026
Aurora Cannabis P/S 2011-2026 | ACB
P/S Jährlich Aurora Cannabis
| 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | 3.73 | 2.99 | 8.94 | 54.4 | 42 | 38.8 | - | - | - | - | - |
Alle Zahlen in CAD-Währung
Indikatorenreichweite aus Jahresberichten
| Höchstwert | Mindestwert | Durchschnitt |
|---|---|---|
| 54.4 | 2.99 | 25.1 |
P/S anderer Aktien in der Arzneimittelhersteller
| Name | P/S | Preis | % 24h | Marktkapitalisierung | Land | |
|---|---|---|---|---|---|---|
|
Aerie Pharmaceuticals
AERI
|
1.68 | - | - | $ 754 M | ||
|
AcelRx Pharmaceuticals
ACRX
|
18.8 | - | 7.5 % | $ 6.35 M | ||
|
Catalent
CTLT
|
2.48 | - | - | $ 11.5 B | ||
|
Adamis Pharmaceuticals Corporation
ADMP
|
3.78 | - | 0.86 % | $ 117 M | ||
|
DURECT Corporation
DRRX
|
3.72 | - | - | $ 50.1 M | ||
|
Canopy Growth Corporation
CGC
|
0.528 | $ 1.1 | 4.05 % | $ 118 M | ||
|
Endo International plc
ENDP
|
0.0339 | - | - | $ 28.9 M | ||
|
Agile Therapeutics
AGRX
|
0.066 | - | 10.11 % | $ 58.2 M | ||
|
Evoke Pharma
EVOK
|
0.432 | - | - | $ 36.6 M | ||
|
Alimera Sciences
ALIM
|
1.26 | - | - | $ 142 M | ||
|
Cronos Group
CRON
|
77.6 | $ 2.67 | 2.69 % | $ 1.38 B | ||
|
Evolus
EOLS
|
0.913 | $ 5.45 | 31.84 % | $ 351 M | ||
|
Avadel Pharmaceuticals plc
AVDL
|
4.24 | - | - | $ 2.06 B | ||
|
Jupiter Wellness
JUPW
|
118 | - | - | $ 33.6 M | ||
|
China Pharma Holdings
CPHI
|
1 | $ 0.58 | 2.89 % | $ 10.1 M | ||
|
Cumberland Pharmaceuticals
CPIX
|
8.49 | $ 4.06 | -11.35 % | $ 57.1 M | ||
|
Calliditas Therapeutics AB (publ)
CALT
|
6.01 K | - | -0.1 % | $ 2.03 B | ||
|
HEXO Corp.
HEXO
|
0.719 | - | 2.45 % | $ 38.1 M | ||
|
Harrow Health
HROW
|
7.1 | $ 39.71 | 2.86 % | $ 1.46 B | ||
|
Neoleukin Therapeutics
NLTX
|
2.11 | - | - | $ 193 M | ||
|
Athenex
ATNX
|
0.111 | - | -23.39 % | $ 1.76 M | ||
|
Emergent BioSolutions
EBS
|
0.132 | $ 8.78 | -1.46 % | $ 450 M | ||
|
ProPhase Labs
PRPH
|
1.06 | - | - | $ 5.07 M | ||
|
Assertio Holdings
ASRT
|
0.434 | $ 12.06 | 1.39 % | $ 857 M | ||
|
Radius Health
RDUS
|
1.64 | - | - | $ 1.42 B | ||
|
Bausch Health Companies
BHC
|
0.386 | $ 5.61 | -2.01 % | $ 2.05 B | ||
|
Lannett Company
LCI
|
0.0823 | - | 1.15 % | $ 7.11 M | ||
|
Eagle Pharmaceuticals
EGRX
|
1.07 | - | -39.89 % | $ 27.7 M | ||
|
Organogenesis Holdings
ORGO
|
0.86 | $ 2.95 | 2.79 % | $ 388 M | ||
|
OrganiGram Holdings
OGI
|
4.82 | $ 1.4 | 2.19 % | $ 402 M | ||
|
Perrigo Company plc
PRGO
|
0.461 | $ 11.62 | 2.06 % | $ 1.61 B | ||
|
Rockwell Medical
RMTI
|
0.424 | $ 0.9 | -0.17 % | $ 21 M | ||
|
Sundial Growers
SNDL
|
0.0158 | $ 1.56 | 1.63 % | $ 3.37 M | ||
|
TherapeuticsMD
TXMD
|
18.4 | $ 2.23 | 0.23 % | $ 23.3 M | ||
|
Veru
VERU
|
6.39 | $ 2.6 | 3.17 % | $ 351 M | ||
|
Viatris
VTRS
|
1.19 | $ 14.7 | -1.28 % | $ 17.6 B | ||
|
Pacira BioSciences
PCRX
|
5.13 | $ 22.8 | 3.17 % | $ 1.05 B | ||
|
PetIQ
PETQ
|
0.36 | - | 1.64 % | $ 400 M | ||
|
OptiNose
OPTN
|
2.7 | - | - | $ 1.08 B | ||
|
PLx Pharma
PLXP
|
14.4 | - | -27.8 % | $ 2.56 M | ||
|
Recro Pharma
REPH
|
1.41 | - | -4.76 % | $ 65.3 M | ||
|
cbdMD
YCBD
|
0.0863 | $ 0.77 | -1.53 % | $ 3.32 M | ||
|
SCYNEXIS
SCYX
|
0.502 | $ 0.76 | 1.1 % | $ 36.4 M | ||
|
Sonoma Pharmaceuticals
SNOA
|
0.256 | $ 2.69 | -2.18 % | $ 3.34 M | ||
|
Tilray
TLRY
|
1.9 | $ 7.49 | 1.77 % | $ 4.63 B | ||
|
Zynerba Pharmaceuticals
ZYNE
|
895 | - | - | $ 55.5 M |